Radiation after surgery for early-stage tongue cancer with risk factors
Part of Cancer clinical trials.
This trial tests whether adding radiation therapy after surgery helps prevent the return of early-stage tongue cancer in patients who have certain risk factors, such as nerve invasion or poorly differentiated cells. It is for people whose cancer was limited to the front two-thirds of the tongue and was completely removed.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old.
- You have been newly diagnosed with early-stage tongue cancer that was completely removed by surgery.
- The cancer was only in the front two-thirds of your tongue and had not spread to lymph nodes.
- Your cancer had at least one risk factor like nerve invasion, cancer cells in blood vessels, or moderate to low differentiation.
- You have not had radiation, chemotherapy, or targeted therapy before, and you are not pregnant or breastfeeding.
- You are generally well enough to be up and about (ECOG score 0-2).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving radiation after surgery can lower the risk of the cancer coming back for people with oral tongue cancer that has specific high-risk features but not advanced spread. It aims to find the best treatment plan for patients with certain tumor characteristics.
This study compares ways of treating early squamous cell cancer in the tonsil or the tongue base, using either radiation therapy, transoral (through-the-mouth) surgery, or both. It aims to see which approach works best while keeping cancer under control.
This trial compares two standard treatments for a type of throat cancer (oropharyngeal cancer) that has not spread to distant organs. Patients will be randomly assigned to either surgery or a combination of chemotherapy and radiation, to see which approach offers better outcomes.
This study helps doctors plan surgery more individually for early-stage oral (mouth) squamous cell carcinoma. It focuses on using tumor features found during evaluation to guide surgical decisions, aiming to improve treatment accuracy.
This trial compares two different treatments after surgery for advanced head and neck cancer (oral or oropharyngeal). It tests whether radiation therapy or continuing an immunotherapy drug (called PD-1 inhibitor) leads to better survival. This study might help you decide which follow-up treatment could be better for your situation.
This trial compares two ways to treat the neck when oral cancer has spread to one lymph node. It looks at whether doing surgery right away or waiting until problems appear leads to better outcomes.
Hear when a new Oral Tongue Squamous Cell Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.